{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"This endpoint was combined with primary outcome measure, MTD","groups":[{"description":"Denileukin diftitox was IV-infused for 60 minutes (±10 minutes) daily from Day 1 through Day 5 of each Cycle (1 cycle = 3 weeks).","id":"OG000","title":"Denileukin Diftitox"}],"populationDescription":"This endpoint was combined with primary outcome measure, MTD","reportingStatus":"POSTED","timeFrame":"For each dose, first dose of study drug (Cycle 1 Day 1) to end of Cycle 1 (Day 21) (1 cycle = 3 weeks)","title":"Recommended Dose","type":"SECONDARY"}